Occult hepatitis C virus infection in patients with malignant lymphoproliferative disorders. 2020

Abeya A Lotfi, and Asmaa E Mohamed, and Nahela A Shalaby, and Deena S Eissa, and Ehab El-Dabaa, and Ayman M Sallam, and Mahmoud M Kamel, and Hisham Abdelaziz, and Amal M El-Afifi, and Ahmed S Abdel-Moneim
Clinical and Chemical Pathology Department, Theodor Bilharz Research Institute, Giza, Egypt.

Despite the link between HCV and malignant lymphoproliferative disorders has been established, the association between occult hepatitis C virus infection and malignant lymphoproliferative disorders remains obscure. The present study intended to identify the possible association between occult HCV infection and malignant lymphoproliferative disorders. Newly diagnosed patients with LPDs were screened for the presence of HCV-RNA in both plasma and PBMCs. PBMCs of the subjects were also, examined by transmission and immuno-electron microscopy. LPD patients showed a high percentage of HCV infection (71.9%): OCI-HCV (37.5%) and HCV (34.38%). Meanwhile, 28.13% of LPD patients did not show any evidence of HCV infection. Ultrastructural examination of PBMCs revealed the presence of intracytoplasmic vacuoles enclosing viral like particles, which were less prominent in occult HCV patients. The possibility of occult HCV should be considered in patients with LPDs which can be helpful in the management of the treatment protocol in order to set up a balance between the control of the tumor progression and minimizing post chemotherapy complications related to HCV infection.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008232 Lymphoproliferative Disorders Disorders characterized by proliferation of lymphoid tissue, general or unspecified. Duncan's Syndrome,X-Linked Lymphoproliferative Syndrome,Duncan Disease,Epstein-Barr Virus Infection, Familial Fatal,Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males,Familial Fatal Epstein-Barr Infection,Immunodeficiency 5,Immunodeficiency, X-Linked Progressive Combined Variable,Lymphoproliferative Disease, X-Linked,Lymphoproliferative Syndrome, X-Linked, 1,Purtilo Syndrome,X-Linked Lymphoproliferative Disease,X-Linked Lymphoproliferative Disorder,Disease, Duncan,Disease, X-Linked Lymphoproliferative,Diseases, X-Linked Lymphoproliferative,Disorder, Lymphoproliferative,Disorder, X-Linked Lymphoproliferative,Disorders, Lymphoproliferative,Disorders, X-Linked Lymphoproliferative,Epstein Barr Virus Induced Lymphoproliferative Disease In Males,Epstein Barr Virus Infection, Familial Fatal,Familial Fatal Epstein Barr Infection,Immunodeficiency 5s,Immunodeficiency, X Linked Progressive Combined Variable,Lymphoproliferative Disease, X Linked,Lymphoproliferative Diseases, X-Linked,Lymphoproliferative Disorder,Lymphoproliferative Disorder, X-Linked,Lymphoproliferative Disorders, X-Linked,Lymphoproliferative Syndrome, X-Linked,Lymphoproliferative Syndromes, X-Linked,Purtilo Syndromes,Syndrome, Purtilo,Syndrome, X-Linked Lymphoproliferative,Syndromes, Purtilo,Syndromes, X-Linked Lymphoproliferative,X Linked Lymphoproliferative Disease,X Linked Lymphoproliferative Disorder,X Linked Lymphoproliferative Syndrome,X-Linked Lymphoproliferative Diseases,X-Linked Lymphoproliferative Disorders,X-Linked Lymphoproliferative Syndromes
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

Abeya A Lotfi, and Asmaa E Mohamed, and Nahela A Shalaby, and Deena S Eissa, and Ehab El-Dabaa, and Ayman M Sallam, and Mahmoud M Kamel, and Hisham Abdelaziz, and Amal M El-Afifi, and Ahmed S Abdel-Moneim
February 2013, Journal of medical virology,
Abeya A Lotfi, and Asmaa E Mohamed, and Nahela A Shalaby, and Deena S Eissa, and Ehab El-Dabaa, and Ayman M Sallam, and Mahmoud M Kamel, and Hisham Abdelaziz, and Amal M El-Afifi, and Ahmed S Abdel-Moneim
March 1996, British journal of haematology,
Abeya A Lotfi, and Asmaa E Mohamed, and Nahela A Shalaby, and Deena S Eissa, and Ehab El-Dabaa, and Ayman M Sallam, and Mahmoud M Kamel, and Hisham Abdelaziz, and Amal M El-Afifi, and Ahmed S Abdel-Moneim
October 1998, Haematologica,
Abeya A Lotfi, and Asmaa E Mohamed, and Nahela A Shalaby, and Deena S Eissa, and Ehab El-Dabaa, and Ayman M Sallam, and Mahmoud M Kamel, and Hisham Abdelaziz, and Amal M El-Afifi, and Ahmed S Abdel-Moneim
June 2014, Journal of viral hepatitis,
Abeya A Lotfi, and Asmaa E Mohamed, and Nahela A Shalaby, and Deena S Eissa, and Ehab El-Dabaa, and Ayman M Sallam, and Mahmoud M Kamel, and Hisham Abdelaziz, and Amal M El-Afifi, and Ahmed S Abdel-Moneim
January 2012, Hepatitis research and treatment,
Abeya A Lotfi, and Asmaa E Mohamed, and Nahela A Shalaby, and Deena S Eissa, and Ehab El-Dabaa, and Ayman M Sallam, and Mahmoud M Kamel, and Hisham Abdelaziz, and Amal M El-Afifi, and Ahmed S Abdel-Moneim
May 1996, Blood,
Abeya A Lotfi, and Asmaa E Mohamed, and Nahela A Shalaby, and Deena S Eissa, and Ehab El-Dabaa, and Ayman M Sallam, and Mahmoud M Kamel, and Hisham Abdelaziz, and Amal M El-Afifi, and Ahmed S Abdel-Moneim
October 2002, Leukemia,
Abeya A Lotfi, and Asmaa E Mohamed, and Nahela A Shalaby, and Deena S Eissa, and Ehab El-Dabaa, and Ayman M Sallam, and Mahmoud M Kamel, and Hisham Abdelaziz, and Amal M El-Afifi, and Ahmed S Abdel-Moneim
January 2002, The Israel Medical Association journal : IMAJ,
Abeya A Lotfi, and Asmaa E Mohamed, and Nahela A Shalaby, and Deena S Eissa, and Ehab El-Dabaa, and Ayman M Sallam, and Mahmoud M Kamel, and Hisham Abdelaziz, and Amal M El-Afifi, and Ahmed S Abdel-Moneim
November 1995, Blood,
Abeya A Lotfi, and Asmaa E Mohamed, and Nahela A Shalaby, and Deena S Eissa, and Ehab El-Dabaa, and Ayman M Sallam, and Mahmoud M Kamel, and Hisham Abdelaziz, and Amal M El-Afifi, and Ahmed S Abdel-Moneim
September 2000, Digestive diseases and sciences,
Copied contents to your clipboard!